Femaralyn 2,5mg Driada Medical

£60.00

Femaralyn 2.5mg Driada Medical is a pharmaceutical-grade letrozole compound for in-vitro research investigating estrogen receptor modulation and aromatase inhibition mechanisms in laboratory studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Femaralyn 2,5mg Driada Medical
Femaralyn 2,5mg Driada Medical
£60.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Femaralyn 2.5mg Laboratory Compound

Femaralyn 2.5mg by Driada Medical is a pharmaceutical-grade letrozole formulation developed for advanced in-vitro research applications. This research chemical compound enables scientists to investigate aromatase inhibition pathways and estrogen receptor modulation mechanisms in controlled laboratory environments. Researchers at Stroid UK Shop utilise this compound to study hormonal regulation systems and endocrine pathway interactions. The precise 2.5mg dosage formulation provides consistent research parameters for reproducible experimental outcomes in academic and commercial laboratory settings.

Scientific Research Applications

Laboratory studies examine Femaralyn’s mechanism of action in blocking aromatase enzyme activity, which converts androgens to estrogens. Research investigations focus on understanding how letrozole compounds interact with cytochrome P450 enzymes and their role in steroid biosynthesis pathways. Scientists analyse the compound’s selectivity profile and binding affinity to explore its potential applications in endocrine research. Studies complement broader research into estrogen blocker mechanisms alongside investigations into selective androgen receptor modulators and peptide hormone interactions. Research protocols examine dose-response relationships and temporal effects on hormonal feedback loops in controlled experimental conditions.

Laboratory Specifications

Femaralyn 2.5mg Research Compound Specifications
Active Compound Letrozole
Concentration 2.5mg per tablet
Manufacturer Driada Medical
Form Oral tablets
Purity Pharmaceutical grade
Storage Cool, dry conditions
CAS Number Verify with supplier
Molecular Weight Verify with supplier

Research Compliance Statement

Femaralyn 2.5mg is manufactured exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic use, or any applications outside controlled research environments. All research must comply with institutional guidelines and applicable regulations governing laboratory chemical handling and storage protocols.

Related